Pregnancy and Postpartum CGM in GDM

Part of paid clinical trials in New York, New York.

Sponsor
Icahn School of Medicine at Mount Sinai
Study ID
NCT07174245
Status
Recruiting
Apply to this trial

Conditions

  • Gestational Diabetes

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • continuous glucose monitor — DEVICE
    All participants who wear CGM

Study Details

Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.

Key Dates

Start date
Aug 5, 2025
Status verified
Sep 2025
Primary completion
Aug 5, 2026
Completion
Aug 15, 2026

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Participants with Gestational diabetes GDM
    All participants who wear CGM and have their postpartum OGTT

Primary Outcome Measure

Sensitivity of postpartum TIR <96% [ Time Frame: up to 12 weeks postpartum ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Icahn School of Medicine at Mount SinaiNew YorkNew York10029
Shaziah Hassan
[email protected]
212-241-5355
Grenye O'Malley (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Icahn School of Medicine at Mount Sinai· New York, NY

Related Studies